Found: 29
Select item for more details and to access through your institution.
ABI2‐mediated MEOX2/KLF4‐NANOG axis promotes liver cancer stem cell and drives tumour recurrence.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2562, doi. 10.1111/liv.15412
- By:
- Publication type:
- Article
Real‐life experiences with bulevirtide for the treatment of hepatitis delta—48 weeks data from a German centre.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2403, doi. 10.1111/liv.15408
- By:
- Publication type:
- Article
Management of NAFLD in primary care settings.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2377, doi. 10.1111/liv.15404
- By:
- Publication type:
- Article
Acyl‐CoA thioesterase 9 promotes tumour growth and metastasis through reprogramming of fatty acid metabolism in hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2548, doi. 10.1111/liv.15409
- By:
- Publication type:
- Article
Is ageing a problematic hurdle to the efficacy of first‐line atezolizumab plus bevacizumab in hepatocellular carcinoma?
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2352, doi. 10.1111/liv.15418
- By:
- Publication type:
- Article
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2538, doi. 10.1111/liv.15405
- By:
- Publication type:
- Article
Fibrosis nonalcoholic steatohepatitis index validation and applicability considering glycaemic severity and T2D duration.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2577, doi. 10.1111/liv.15406
- By:
- Publication type:
- Article
DLK1‐directed chimeric antigen receptor T‐cell therapy for hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2524, doi. 10.1111/liv.15411
- By:
- Publication type:
- Article
No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single‐centre in Milan.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2581, doi. 10.1111/liv.15400
- By:
- Publication type:
- Article
Using machine learning for predicting outcomes in ACLF.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2354, doi. 10.1111/liv.15399
- By:
- Publication type:
- Article
Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2513, doi. 10.1111/liv.15396
- By:
- Publication type:
- Article
Rotational thromboelastometry‐guided blood component use in cirrhotic children undergoing invasive procedures: Randomized controlled trial.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2492, doi. 10.1111/liv.15398
- By:
- Publication type:
- Article
The immuno‐therapeutic potential of miR‐2392 in patients with hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2585, doi. 10.1111/liv.15395
- By:
- Publication type:
- Article
Recommendations for histological criteria of autoimmune hepatitis from the international AIH pathology: Validation on a monocentric cohort.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2583, doi. 10.1111/liv.15394
- By:
- Publication type:
- Article
Histologic criteria of autoimmune hepatitis: Is there anything left to discuss?
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2587, doi. 10.1111/liv.15391
- Publication type:
- Article
Similar risk of kidney function decline between tenofovir alafenamide and besifovir dipivoxil maleate in chronic hepatitis B.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2408, doi. 10.1111/liv.15388
- By:
- Publication type:
- Article
Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community‐based cross‐sectional study.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2396, doi. 10.1111/liv.15390
- By:
- Publication type:
- Article
Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2453, doi. 10.1111/liv.15386
- By:
- Publication type:
- Article
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2428, doi. 10.1111/liv.15385
- By:
- Publication type:
- Article
Inhibition of polyploidization in Pten‐deficient livers reduces steatosis.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2442, doi. 10.1111/liv.15384
- By:
- Publication type:
- Article
Extrahepatic autoimmune diseases in autoimmune hepatitis: Effect on mortality.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2466, doi. 10.1111/liv.15382
- By:
- Publication type:
- Article
Changing trends in aetiology‐based hospitalizations with end‐stage liver disease in the United States from 2016 to 2019.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2390, doi. 10.1111/liv.15381
- By:
- Publication type:
- Article
Predicting liver‐related serious adverse events in patients with primary biliary cholangitis‐related cirrhosis treated with obeticholic acid.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Assessment of glomerular filtration rate in patients with cirrhosis: Available tools and perspectives.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2360, doi. 10.1111/liv.15198
- By:
- Publication type:
- Article
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2501, doi. 10.1111/liv.15365
- By:
- Publication type:
- Article
Patient‐reported outcomes and their relation with iron parameters in HFE haemochromatosis during maintenance therapy: A prospective cohort study.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2473, doi. 10.1111/liv.15341
- By:
- Publication type:
- Article
Hepatic ultrastructural features distinguish paediatric Wilson disease from NAFLD and autoimmune hepatitis.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2482, doi. 10.1111/liv.15319
- By:
- Publication type:
- Article
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2418, doi. 10.1111/liv.15377
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2347, doi. 10.1111/liv.14961
- Publication type:
- Article